Prospective study to determine the effect of bisphosphonate and SERM on bone markers in postmenopausal women with osteoporosis and type 2 diabetes.
Not Applicable
- Conditions
- Type 2 diabetes
- Registration Number
- JPRN-UMIN000008783
- Lead Sponsor
- Department of Medicine II, Hokkaido University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who don't agreed with written consent form. Patients who are expected to change hypoglycemic agents, especially pioglitazone and incretin-based therapies, during observation period. Patients who have been treated with Bisphosphonate, SERM or PTH within 6 months. Patients who are suited for contraindications of bisphosphonate and SERM. Patients who are inappropriate for this study by research director.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method